接种10价肺炎链球菌流感嗜血杆菌蛋白D结合疫苗的慢性支气管化脓性患儿下呼吸道不可分型流感嗜血杆菌感染减少
研究纳入543名因慢性咳嗽接受支气管镜检查的儿童,比较接种10价肺炎链球菌不可分型流感嗜血杆菌蛋白D结合疫苗(PHiD-CV)与未接种者下呼吸道不可分型流感嗜血杆菌(NTHi)感染情况。PHiD-CV接种者NTHi下呼吸道感染检出率为17%,低于PCV7接种者的34%和PCV13接种者的28%。多因素回归显示PHiD-CV接种与NTHi下呼吸道感染减少独立相关(OR=0.42,95%CI 0.19-0.93)。
要点
- PHiD-CV接种儿童NTHi下呼吸道感染检出率17%,低于PCV7接种者的34%和PCV13接种者的28%。
- 多因素回归中PHiD-CV接种与NTHi下呼吸道感染减少独立相关(OR=0.42,95%CI 0.19-0.93)。
- PHiD-CV接种对NTHi鼻咽部携带无影响。
核心结论
- 接种PHiD-CV的儿童发生NTHi下呼吸道感染的可能性显著低于未接种PHiD-CV的儿童。
- PHiD-CV可能是减少有慢性化脓性肺疾病风险儿童NTHi支气管内膜感染的有效干预措施。
研究设计与样本
- 前瞻性收集2007-2016年543名因慢性咳嗽接受支气管镜检查儿童的配对支气管肺泡灌洗液和鼻咽拭子。
- 接种≥2剂一种肺炎链球菌结合疫苗(PCV)且<2剂另一种PCV的儿童纳入相应疫苗组。
- 采用 logistic 回归分析NTHi下呼吸道感染(支气管肺泡灌洗液≥10^4 CFU/mL)与年龄、性别、原住民身份、抗生素暴露和PHiD-CV接种的关联。
主要发现
- 262名PCV7接种儿童中89名(34%)检出NTHi下呼吸道感染。
- 53名PHiD-CV接种儿童中9名(17%)检出NTHi下呼吸道感染。
- 166名PCV13接种儿童中47名(28%)检出NTHi下呼吸道感染。
- 多因素回归中与NTHi下呼吸道感染减少独立相关的因素包括PHiD-CV接种(OR=0.42,95%CI 0.19-0.93)、大环内酯类使用(OR=0.57,95%CI 0.35-0.93)和年龄增长(OR=0.88,95%CI 0.80-0.96)。
- PHiD-CV接种对NTHi鼻咽部携带无影响。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Nontypeable Haemophilus influenzae (NTHi), the most common bacterial lower airway infection in children with protracted bacterial bronchitis, is associated with progression to bronchiectasis. We determined whether vaccination with 10-valent pneumococcal NTHi protein-D conjugate vaccine (PHiD-CV) reduced NTHi lower airway infection compared to children not PHiD-CV-vaccinated. Our unique childhood vaccination schedule and prospective 9-year bronchoalveolar lavage (BAL) collection provided an exclusive opportunity to examine this hypothesis. METHODS: Paired BAL fluids and nasopharyngeal (NP) swabs were collected from 543 children (2007-2016) undergoing bronchoscopy for chronic cough. Children who received a primary course of ≥2 doses of one pneumococcal conjugate vaccine (PCV) and <2 doses of another PCV were included in each vaccine group. Logistic regression determined associations between NTHi lower airway infection (≥104 colony-forming units/mL BAL) and age, sex, Indigenous status, antibiotic exposure, and PHiD-CV vaccination. RESULTS: Of 262 PCV7-vaccinated, 53 PHiD-CV-vaccinated and 166 PCV13-vaccinated children (62 had mixed schedules, <2 PCV doses or missing vaccination data), NTHi lower airway infection was detected in 89 (34%), 9 (17%) and 47 (28%), respectively. On multivariate regression, significant independent factors associated with reduced NTHi lower airway infection were PHiD-CV vaccination (ORadjusted = 0.42, 95%CI 0.19-0.93), macrolide use (ORadjusted = 0.57, 95%CI 0.35-0.93) and increasing age (ORadjusted = 0.88, 95%CI 0.80-0.96). PHiD-CV vaccination had no impact on NTHi NP carriage. CONCLUSIONS: PHiD-CV-vaccinated children were significantly less likely to have NTHi lower airway infection than children not PHiD-CV-vaccinated. PHiD-CV is likely an effective intervention for reducing NTHi endobronchial infection in children at risk of chronic suppurative lung diseases.
引用
- Hare KM, Smith-Vaughan HC, Leach AJ, et al. Reduced nontypeable Haemophilus influenzae lower airway infection in children with chronic endobronchial suppuration vaccinated with the 10-valent pneumococcal H. influenzae protein D conjugate vaccine. Vaccine. 2018. PMID: 29478754. doi:10.1016/j.vaccine.2018.02.054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。